Dynatrace (DT) director reports 519 RSUs vested, now holding 8,651 shares

Rhea-AI Filing Summary

Dynatrace, Inc. director reports vesting of restricted stock units

A Dynatrace, Inc. director filed a Form 4 reporting the vesting and settlement of time-based restricted stock units into common stock. On 12/01/2025, 519 RSUs were converted into 519 shares of Dynatrace common stock, increasing the director’s directly held common stock to 8,651 shares. The RSUs were originally granted on September 1, 2023, with 25% vesting on September 1, 2024 and the remaining units vesting in equal quarterly installments through September 1, 2027, subject to continued board service.

After this transaction, the director also continues to hold 3,631 RSUs, each representing a contingent right to receive one share of Dynatrace common stock if future vesting conditions are met.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kulkarni Amol

(Last) (First) (Middle)

C/O DYNATRACE, INC.

280 CONGRESS STREET, 11TH FLOOR

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dynatrace, Inc. [ DT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		M(1)		519	A	(1)	8,651	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/01/2025		M			519	(2)	(1)	Common Stock	519	$0	3,631	D

Explanation of Responses:

1. Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.

2. Represents the vesting of RSUs granted on September 1, 2023. 25% of the RSUs granted vested on September 1, 2024 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested on September 1, 2027, subject to the Reporting Person's continued service as director of the Issuer on the applicable vesting dates.

Remarks:

	/s/ Marc Gold, by power of attorney	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dynatrace (DT) report in this Form 4?

A Dynatrace, Inc. director reported the vesting and settlement of 519 restricted stock units into 519 shares of Dynatrace common stock on 12/01/2025.

How many Dynatrace (DT) shares does the reporting person own after the transaction?

Following the 12/01/2025 transaction, the reporting person beneficially owns 8,651 shares of Dynatrace common stock directly.

How many restricted stock units does the Dynatrace (DT) director still hold?

After the reported transaction, the director holds 3,631 restricted stock units, each representing a contingent right to receive one Dynatrace common share upon vesting.

What are the vesting terms of the Dynatrace (DT) RSUs granted on September 1, 2023?

For the RSUs granted on September 1, 2023, 25% vested on September 1, 2024, and the remaining units vest in equal quarterly installments until fully vested on September 1, 2027, subject to continued service as a director.

Did the Dynatrace (DT) director pay a cash exercise price for the RSUs?

The reported RSUs converted into common stock at a price of $0 for the derivative security, which is typical for time-based restricted stock units.

What is the reporting person’s relationship to Dynatrace (DT)?

The filing identifies the reporting person’s relationship to Dynatrace, Inc. as a director of the company.